{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:44:58Z","timestamp":1791233098177,"version":"4.1.0"},"reference-count":97,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100002347","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["\u201cADITEC\u201d, Grant no.: HEALTH-F4-2011-280873"],"award-info":[{"award-number":["\u201cADITEC\u201d, Grant no.: HEALTH-F4-2011-280873"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["\u201cTBVAC2020\u201d, Grant no.: 643381"],"award-info":[{"award-number":["\u201cTBVAC2020\u201d, Grant no.: 643381"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["GC6-2013, grant no. #OPP 1055806 and #OPP 1065330"],"award-info":[{"award-number":["GC6-2013, grant no. #OPP 1055806 and #OPP 1065330"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["\u201cInfect Control 2020\u201d, Grant no. 03ZZ0806A"],"award-info":[{"award-number":["\u201cInfect Control 2020\u201d, Grant no. 03ZZ0806A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01147","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T04:36:24Z","timestamp":1505795784000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":193,"title":["The Recombinant Bacille Calmette\u2013Gu\u00e9rin Vaccine VPM1002: Ready for Clinical Efficacy Testing"],"prefix":"10.3389","volume":"8","author":[{"given":"Natalie E.","family":"Nieuwenhuizen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad S.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh","family":"Shaligram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark F.","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrill A.","family":"Rentsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Eisele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leander","family":"Grode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan H. E.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,9,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1128\/cvi.00349-16","article-title":"In vitro experimental model of trained innate immunity in human primary monocytes","volume":"23","author":"Bekkering","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/ni.2961","article-title":"Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges","volume":"15","author":"Aaby","year":"2014","journal-title":"Nat Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"i5225","DOI":"10.1136\/bmj.i5225","article-title":"Non-specific immunological effects of selected routine childhood immunisations: systematic review","volume":"355","author":"Kandasamy","year":"2016","journal-title":"BMJ"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1086\/513642","article-title":"Disseminated bacille Calmette-Guerin disease after vaccination: case report and review","volume":"24","author":"Talbot","year":"1997","journal-title":"Clin Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S2213-2600(14)70033-5","article-title":"Progress in tuberculosis vaccine development and host-directed therapies \u2013 a state of the art review","volume":"2","author":"Kaufmann","year":"2014","journal-title":"Lancet Respir Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1586\/14760584.2014.905746","article-title":"The BCG replacement vaccine VPM1002: from drawing board to clinical trial","volume":"13","author":"Kaufmann","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.vaccine.2012.12.053","article-title":"Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial","volume":"31","author":"Grode","year":"2013","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"8768","DOI":"10.1073\/pnas.92.19.8768","article-title":"The urease locus of Mycobacterium tuberculosis and its utilization for the demonstration of allelic exchange in Mycobacterium bovis bacillus Calmette-Guerin","volume":"92","author":"Reyrat","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/286079a0","article-title":"Ammonia inhibits phagosome-lysosome fusion in macrophages","volume":"286","author":"Gordon","year":"1980","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.tim.2012.04.006","article-title":"Listeriolysin O: the Swiss army knife of Listeria","volume":"20","author":"Hamon","year":"2012","journal-title":"Trends Microbiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/j.1462-5822.2005.00665.x","article-title":"Membrane perforations inhibit lysosome fusion by altering pH and calcium in Listeria monocytogenes vacuoles","volume":"8","author":"Shaughnessy","year":"2006","journal-title":"Cell Microbiol"},{"key":"B12","first-page":"53","article-title":"History of BCG vaccine","volume":"8","author":"Luca","year":"2013","journal-title":"Maedica (Buchar)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1128\/IAI.74.1.88-98.2006","article-title":"Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence","volume":"74","author":"Brodin","year":"2006","journal-title":"Infect Immun"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mib.2008.11.003","article-title":"ESX\/type VII secretion systems and their role in host-pathogen interaction","volume":"12","author":"Simeone","year":"2009","journal-title":"Curr Opin Microbiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1073\/pnas.1620133114","article-title":"Mycobacterial ESX-1 secretion system mediates host cell lysis through bacterium contact-dependent gross membrane disruptions","volume":"114","author":"Conrad","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B16","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1128\/IAI.55.9.2037-2041.1987","article-title":"Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells","volume":"55","author":"Muller","year":"1987","journal-title":"Infect Immun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.it.2012.03.004","article-title":"Tuberculosis vaccine development: strength lies in tenacity","volume":"33","author":"Kaufmann","year":"2012","journal-title":"Trends Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.tube.2016.09.004","article-title":"Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations","volume":"101","author":"Sharpe","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e1000392","DOI":"10.1371\/journal.ppat.1000392","article-title":"A critical role for CD8 T cells in a nonhuman primate model of tuberculosis","volume":"5","author":"Chen","year":"2009","journal-title":"PLoS Pathog"},{"key":"B20","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/j.1574-6976.2008.00118.x","article-title":"Influence of BCG vaccine strain on the immune response and protection against tuberculosis","volume":"32","author":"Ritz","year":"2008","journal-title":"FEMS Microbiol Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"6311","DOI":"10.4049\/jimmunol.1300248","article-title":"Control of chronic Mycobacterium tuberculosis infection by CD4 KLRG1- IL-2-secreting central memory cells","volume":"190","author":"Lindenstrom","year":"2013","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.4049\/jimmunol.178.5.3143","article-title":"The type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis","volume":"178","author":"Stanley","year":"2007","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/eji.201141548","article-title":"Activation of the NLRP3 inflammasome by Mycobacterium tuberculosis is uncoupled from susceptibility to active tuberculosis","volume":"42","author":"Dorhoi","year":"2012","journal-title":"Eur J Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.chom.2015.05.003","article-title":"Mycobacterium tuberculosis differentially activates cGAS- and inflammasome-dependent intracellular immune responses through ESX-1","volume":"17","author":"Wassermann","year":"2015","journal-title":"Cell Host Microbe"},{"key":"B25","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.cell.2012.06.040","article-title":"Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway","volume":"150","author":"Watson","year":"2012","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/nm906","article-title":"Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis","volume":"9","author":"Schaible","year":"2003","journal-title":"Nat Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.immuni.2005.12.001","article-title":"Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis","volume":"24","author":"Winau","year":"2006","journal-title":"Immunity"},{"key":"B28","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1172\/JCI77014","article-title":"Annexin1 regulates DC efferocytosis and cross-presentation during Mycobacterium tuberculosis infection","volume":"125","author":"Tzelepis","year":"2015","journal-title":"J Clin Invest"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/infdis\/jiu675","article-title":"The recombinant BCG \u0394ureC::hly vaccine targets the AIM2 inflammasome to induce autophagy and inflammation","volume":"211","author":"Saiga","year":"2015","journal-title":"J Infect Dis"},{"key":"B30","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.4049\/jimmunol.139.6.2032","article-title":"Importance of L3T4+ and Lyt-2+ cells in the immunologic control of infection with Mycobacterium bovis strain bacillus Calmette-Guerin in mice. Assessment by elimination of T cell subsets in vivo","volume":"139","author":"Pedrazzini","year":"1987","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1128\/IAI.72.7.4200-4209.2004","article-title":"Mycobacterium bovis BCG urease attenuates major histocompatibility complex class II trafficking to the macrophage cell surface","volume":"72","author":"Sendide","year":"2004","journal-title":"Infect Immun"},{"key":"B32","doi-asserted-by":"publisher","first-page":"5687","DOI":"10.4049\/jimmunol.174.9.5687","article-title":"Mycobacteria inhibition of IFN-gamma induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells","volume":"174","author":"Wang","year":"2005","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1128\/IAI.72.4.2101-2110.2004","article-title":"Inhibition of major histocompatibility complex II expression and antigen processing in murine alveolar macrophages by Mycobacterium bovis BCG and the 19-kilodalton mycobacterial lipoprotein","volume":"72","author":"Fulton","year":"2004","journal-title":"Infect Immun"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.1073\/pnas.95.9.5299","article-title":"Mycobacterium bovis bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes","volume":"95","author":"Hess","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Invest"},{"key":"B36","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/ni.1904","article-title":"Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis","volume":"11","author":"Divangahi","year":"2010","journal-title":"Nat Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"9623","DOI":"10.1038\/srep09623","article-title":"Plasticity of listeriolysin O pores and its regulation by pH and unique histidine [corrected]","volume":"5","author":"Podobnik","year":"2015","journal-title":"Sci Rep"},{"key":"B38","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S1286-4579(99)80077-X","article-title":"Cytolytic T-cell responses to human dendritic cells and macrophages infected with Mycobacterium bovis BCG and recombinant BCG secreting listeriolysin","volume":"1","author":"Conradt","year":"1999","journal-title":"Microbes Infect"},{"key":"B39","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3390\/vaccines1020120","article-title":"Nonclinical development of BCG replacement vaccine candidates","volume":"1","author":"Velmurugan","year":"2013","journal-title":"Vaccines (Basel)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/sj.cdd.4400859","article-title":"Triggering of apoptosis by cathepsins","volume":"8","author":"Leist","year":"2001","journal-title":"Cell Death Differ"},{"key":"B41","doi-asserted-by":"publisher","first-page":"7608","DOI":"10.1016\/j.vaccine.2012.10.031","article-title":"The recombinant tuberculosis vaccine rBCG \u0394ureC::hly(+) induces apoptotic vesicles for improved priming of CD4(+) and CD8(+) T cells","volume":"30","author":"Farinacci","year":"2012","journal-title":"Vaccine"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1128\/IAI.73.4.1907-1916.2005","article-title":"Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells","volume":"73","author":"Fink","year":"2005","journal-title":"Infect Immun"},{"key":"B43","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","article-title":"The inflammasomes: guardians of the body","volume":"27","author":"Martinon","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nature07710","article-title":"AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA","volume":"458","author":"Fernandes-Alnemri","year":"2009","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nature07725","article-title":"AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC","volume":"458","author":"Hornung","year":"2009","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","article-title":"Autophagy in the pathogenesis of disease","volume":"132","author":"Levine","year":"2008","journal-title":"Cell"},{"key":"B47","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nm.1928","article-title":"Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells","volume":"15","author":"Jagannath","year":"2009","journal-title":"Nat Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nri3532","article-title":"Autophagy in infection, inflammation and immunity","volume":"13","author":"Deretic","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e1006344","DOI":"10.1371\/journal.ppat.1006344","article-title":"Mycobacterium marinum antagonistically induces an autophagic response while repressing the autophagic flux in a TORC1- and ESX-1-dependent manner","volume":"13","author":"Cardenal-Munoz","year":"2017","journal-title":"PLoS Pathog"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.3273","article-title":"Autophagy and autophagy-related proteins in the immune system","volume":"16","author":"Shibutani","year":"2015","journal-title":"Nat Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e11479","DOI":"10.7554\/eLife.11479","article-title":"Guanylate binding proteins directly attack Toxoplasma gondii via supramolecular complexes","volume":"5","author":"Kravets","year":"2016","journal-title":"Elife"},{"key":"B52","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nature13157","article-title":"Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases","volume":"509","author":"Meunier","year":"2014","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ni.3440","article-title":"Interferon-induced guanylate-binding proteins in inflammasome activation and host defense","volume":"17","author":"Kim","year":"2016","journal-title":"Nat Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1189\/jlb.4MR0516-223R","article-title":"Interferon-inducible guanylate-binding proteins at the interface of cell-autonomous immunity and inflammasome activation","volume":"101","author":"Man","year":"2017","journal-title":"J Leukoc Biol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e1005770","DOI":"10.1371\/journal.ppat.1005770","article-title":"CD4+ T cells recognizing PE\/PPE antigens directly or via cross reactivity are protective against pulmonary Mycobacterium tuberculosis infection","volume":"12","author":"Sayes","year":"2016","journal-title":"PLoS Pathog"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1016\/j.celrep.2017.02.057","article-title":"Recombinant BCG expressing ESX-1 of Mycobacterium marinum combines low virulence with cytosolic immune signaling and improved TB protection","volume":"18","author":"Groschel","year":"2017","journal-title":"Cell Rep"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1172\/JCI84978","article-title":"ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo","volume":"126","author":"Kupz","year":"2016","journal-title":"J Clin Invest"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1093\/infdis\/jir592","article-title":"Recombinant BCG DeltaureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses","volume":"204","author":"Desel","year":"2011","journal-title":"J Infect Dis"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/infdis\/jiu347","article-title":"Central memory CD4+ T cells are responsible for the recombinant bacillus Calmette-Guerin \u0394ureC::hly vaccine\u2019s superior protection against tuberculosis","volume":"210","author":"Vogelzang","year":"2014","journal-title":"J Infect Dis"},{"key":"B60","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.micinf.2016.03.005","article-title":"Post-exposure vaccination with the vaccine candidate bacillus Calmette-Guerin \u0394ureC::hly induces superior protection in a mouse model of subclinical tuberculosis","volume":"18","author":"Gengenbacher","year":"2016","journal-title":"Microbes Infect"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e679","DOI":"10.1128\/mBio.00679-16","article-title":"Deletion of nuoG from the vaccine candidate Mycobacterium bovis BCG \u0394ureC::hly improves protection against tuberculosis","volume":"7","author":"Gengenbacher","year":"2016","journal-title":"MBio"},{"key":"B62","doi-asserted-by":"publisher","first-page":"13894","DOI":"10.1038\/ncomms13894","article-title":"Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy","volume":"7","author":"Griffiths","year":"2016","journal-title":"Nat Commun"},{"key":"B63","doi-asserted-by":"publisher","first-page":"5556","DOI":"10.4049\/jimmunol.1002828","article-title":"CXCR5 expressing human central memory CD4 T cells and their relevance for humoral immune responses","volume":"186","author":"Chevalier","year":"2011","journal-title":"J Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"19570","DOI":"10.1038\/srep19570","article-title":"Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens","volume":"6","author":"Knudsen","year":"2016","journal-title":"Sci Rep"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e113951","DOI":"10.1371\/journal.pone.0113951","article-title":"Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice","volume":"9","author":"Nandakumar","year":"2014","journal-title":"PLoS One"},{"key":"B66","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1172\/JCI65728","article-title":"CXCR5(+) T helper cells mediate protective immunity against tuberculosis","volume":"123","author":"Slight","year":"2013","journal-title":"J Clin Invest"},{"key":"B67","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1073\/pnas.1611776114","article-title":"Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis","volume":"114","author":"Li","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B68","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A functional role for antibodies in tuberculosis","volume":"167","author":"Lu","year":"2016","journal-title":"Cell"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.15252\/emmm.201606330","article-title":"Human isotype-dependent inhibitory antibody responses against Mycobacterium tuberculosis","volume":"8","author":"Zimmermann","year":"2016","journal-title":"EMBO Mol Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e1006250","DOI":"10.1371\/journal.ppat.1006250","article-title":"Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine","volume":"13","author":"Prados-Rosales","year":"2017","journal-title":"PLoS Pathog"},{"key":"B71","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/imr.12276","article-title":"B cells and antibodies in the defense against Mycobacterium tuberculosis infection","volume":"264","author":"Achkar","year":"2015","journal-title":"Immunol Rev"},{"key":"B72","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1002\/eji.201040731","article-title":"Polyfunctional T cells in human tuberculosis","volume":"40","author":"Wilkinson","year":"2010","journal-title":"Eur J Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"8047","DOI":"10.4049\/jimmunol.0801592","article-title":"Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells","volume":"182","author":"Lindenstrom","year":"2009","journal-title":"J Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e439","DOI":"10.1128\/CVI.00439-16","article-title":"Safety and immunogenicity of the recombinant Mycobacterium bovis BCG vaccine VPM1002 in HIV-unexposed newborn infants in South Africa","volume":"24","author":"Loxton","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1097\/QAD.0b013e32834bba0a","article-title":"Impaired bacillus Calmette-Guerin cellular immune response in HIV-exposed, uninfected infants","volume":"25","author":"Mazzola","year":"2011","journal-title":"AIDS"},{"key":"B77","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: a global overview and recent trends","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur Urol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"17022","DOI":"10.1038\/nrdp.2017.22","article-title":"Bladder cancer","volume":"3","author":"Sanli","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"B79","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1177\/107327481001700406","article-title":"Bladder cancer: a review of non-muscle invasive disease","volume":"17","author":"Sexton","year":"2010","journal-title":"Cancer Control"},{"key":"B80","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/RRU.S63447","article-title":"Immunotherapy for bladder cancer","volume":"7","author":"Fuge","year":"2015","journal-title":"Res Rep Urol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"key":"B82","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1586\/14760584.2015.1068124","article-title":"Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy","volume":"14","author":"Zheng","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"B83","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.eururo.2014.11.031","article-title":"Therapeutic options in high-risk non-muscle-invasive bladder cancer during the current worldwide shortage of bacille Calmette-Guerin","volume":"67","author":"Mostafid","year":"2015","journal-title":"Eur Urol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.juro.2016.12.090","article-title":"Intravesical therapy for the treatment of nonmuscle invasive bladder cancer: a systematic review and meta-analysis","volume":"197","author":"Chou","year":"2017","journal-title":"J Urol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e0164792","DOI":"10.1371\/journal.pone.0164792","article-title":"Differential adverse event profiles associated with BCG as a preventive tuberculosis vaccine or therapeutic bladder cancer vaccine identified by comparative ontology-based VAERS and literature meta-analysis","volume":"11","author":"Xie","year":"2016","journal-title":"PLoS One"},{"key":"B86","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.diagmicrobio.2016.04.006","article-title":"Differences between a probable and proven BCG infection following intravesical instillations: 16 years experience in a tertiary care hospital","volume":"85","author":"Gonzalez-Del Vecchio","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"B87","doi-asserted-by":"publisher","first-page":"821526","DOI":"10.1155\/2013\/821526","article-title":"Systemic BCG-osis as a rare side effect of intravesical BCG treatment for superficial bladder cancer","volume":"2013","author":"Lukacs","year":"2013","journal-title":"Case Rep Urol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00262-016-1945-z","article-title":"Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer","volume":"66","author":"Pichler","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"B89","doi-asserted-by":"publisher","first-page":"8250","DOI":"10.1158\/0008-5472.CAN-06-1416","article-title":"Neutrophil granulocytes are required for effective bacillus Calmette-Guerin immunotherapy of bladder cancer and orchestrate local immune responses","volume":"66","author":"Suttmann","year":"2006","journal-title":"Cancer Res"},{"key":"B90","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/bju.12261","article-title":"Modulating the immune response to bacillus Calmette-Guerin (BCG): a novel way to increase the immunotherapeutic effect of BCG for treatment of bladder cancer?","volume":"112","author":"Sapre","year":"2013","journal-title":"BJU Int"},{"key":"B91","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.rmed.2003.12.003","article-title":"Analysis of local T lymphocyte subsets upon stimulation with intravesical BCG: a model to study tuberculosis immunity","volume":"98","author":"Ponticiello","year":"2004","journal-title":"Respir Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"137ra72","DOI":"10.1126\/scitranslmed.3003586","article-title":"Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer","volume":"4","author":"Biot","year":"2012","journal-title":"Sci Transl Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.eururo.2014.02.061","article-title":"Bacillus Calmette-Guerin strain differences have an impact on clinical outcome in bladder cancer immunotherapy","volume":"66","author":"Rentsch","year":"2014","journal-title":"Eur Urol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12967-016-0891-z","article-title":"Clinical significance of T-bet, GATA-3, and Bcl-6 transcription factor expression in bladder carcinoma","volume":"14","author":"Bahria-Sediki","year":"2016","journal-title":"J Transl Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"e1262","DOI":"10.1128\/mBio.01262-14","article-title":"Dietary pyridoxine controls efficacy of vitamin B6-auxotrophic tuberculosis vaccine bacillus Calmette-Guerin \u0394ureC::hly Deltapdx1 in mice","volume":"5","author":"Gengenbacher","year":"2014","journal-title":"MBio"},{"key":"B96","doi-asserted-by":"publisher","first-page":"e0004232","DOI":"10.1371\/journal.pntd.0004232","article-title":"Comparative genomics of field isolates of Mycobacterium bovis and M. caprae provides evidence for possible correlates with bacterial viability and virulence","volume":"9","author":"de la Fuente","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"B97","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1073\/pnas.052548299","article-title":"A new evolutionary scenario for the Mycobacterium tuberculosis complex","volume":"99","author":"Brosch","year":"2002","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01147\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T21:47:56Z","timestamp":1693000076000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01147\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,19]]},"references-count":97,"alternative-id":["10.3389\/fimmu.2017.01147"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01147","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,19]]},"article-number":"1147"}}